Clinical Trial on the Effect of the Sublimated Mare Milk Supplement on Primary Biliary Cholangitis

• Status: Completed
• Trial end date: 2020-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This study evaluates the effect of sublimated mare milk supplement on patients with biliary cholangitis

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Scientific Medical Center, Kazakhstan
• Collaborators: Eurasia Invest Ltd.; Ministry of Education and Science, Republic of Kazakhstan
• Treatments: Ursodeoxycholic Acid

Criteria

Inclusion Criteria:

• Patients with morphologically verified diagnosis of primary biliary cholangitis

• Aged 18 to 75 years

• Willingness to consent to participate in the study

• Consent to adhere to treatment

Exclusion Criteria:

• Alcohol and/or drug dependence

• Presence of liver cirrhosis class C based on Child Pugh classification

• Allergic reaction to dairy products

• Presence of mental diseases, severe concomitant pathology

• Pregnancy and/or lactation

• Lactose intolerance

• Refusal to participate in the study